Nayak I, Biondo R, Stewart W, Fulton R, Moker N, Zhang C
Immunol Cell Biol. 2025; 103(2):192-212.
PMID: 39865344
PMC: 11792776.
DOI: 10.1111/imcb.12848.
Bongrand P
Int J Mol Sci. 2025; 25(24.
PMID: 39769135
PMC: 11676049.
DOI: 10.3390/ijms252413371.
Han J, Wang H
Exp Mol Med. 2024; 56(12):2559-2568.
PMID: 39617785
PMC: 11671598.
DOI: 10.1038/s12276-024-01353-5.
Cao H, Xiao J, Baylink D, Nguyen V, Shim N, Lee J
Biomedicines. 2024; 12(10).
PMID: 39457563
PMC: 11504511.
DOI: 10.3390/biomedicines12102250.
Bar O, Porgador A, Cooks T
J Extracell Biol. 2024; 3(9):e70011.
PMID: 39328262
PMC: 11424882.
DOI: 10.1002/jex2.70011.
Posttranslationally modified self-peptides promote hypertension in mouse models.
Bloodworth N, Chen W, Hunter K, Patrick D, Palubinsky A, Phillips E
J Clin Invest. 2024; 134(16).
PMID: 39145457
PMC: 11324298.
DOI: 10.1172/JCI174374.
Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy.
Mohammad Taheri M, Javan F, Poudineh M, Athari S
J Transl Med. 2024; 22(1):736.
PMID: 39103889
PMC: 11302387.
DOI: 10.1186/s12967-024-05534-8.
Probing T-cell activation in nanoliter tumor co-cultures using membrane displacement trap arrays.
Yeh M, Salazar-Cavazos E, Krishnan A, Altan-Bonnet G, DeVoe D
Integr Biol (Camb). 2024; 16.
PMID: 39074471
PMC: 11286267.
DOI: 10.1093/intbio/zyae014.
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.
Mohammad Taheri M, Javan F, Poudineh M, Athari S
Clin Rev Allergy Immunol. 2024; 66(3):328-362.
PMID: 38995478
DOI: 10.1007/s12016-024-08998-0.
Divergent local and systemic antitumor response in primary uveal melanomas.
Lucibello F, Lalanne A, Le Gac A, Soumare A, Aflaki S, Cyrta J
J Exp Med. 2024; 221(6).
PMID: 38563818
PMC: 10986814.
DOI: 10.1084/jem.20232094.
Comparison of the Capacity of Several Machine Learning Tools to Assist Immunofluorescence-Based Detection of Anti-Neutrophil Cytoplasmic Antibodies.
Bertin D, Bongrand P, Bardin N
Int J Mol Sci. 2024; 25(6).
PMID: 38542244
PMC: 10969855.
DOI: 10.3390/ijms25063270.
Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics.
This S, Costantino S, Melichar H
Sci Adv. 2024; 10(10):eadk2298.
PMID: 38446885
PMC: 10917351.
DOI: 10.1126/sciadv.adk2298.
Cbl-b mitigates the responsiveness of naive CD8 T cells that experience extensive tonic T cell receptor signaling.
Eggert J, Zinzow-Kramer W, Hu Y, Kolawole E, Tsai Y, Weiss A
Sci Signal. 2024; 17(822):eadh0439.
PMID: 38319998
PMC: 10897907.
DOI: 10.1126/scisignal.adh0439.
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output.
Song H, Benzaoui M, Dwivedi A, Underwood S, Shao L, Achar S
Mol Ther Methods Clin Dev. 2024; 32(1):101171.
PMID: 38298420
PMC: 10827561.
DOI: 10.1016/j.omtm.2023.101171.
Antigen perception in T cells by long-term Erk and NFAT signaling dynamics.
Wither M, White W, Pendyala S, Leanza P, Fowler D, Kueh H
Proc Natl Acad Sci U S A. 2023; 120(52):e2308366120.
PMID: 38113261
PMC: 10756264.
DOI: 10.1073/pnas.2308366120.
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.
Gaud G, Achar S, Bourassa F, Davies J, Hatzihristidis T, Choi S
Nat Immunol. 2023; 24(12):2121-2134.
PMID: 37945821
PMC: 11482260.
DOI: 10.1038/s41590-023-01663-2.
Recent advances in understanding TCR signaling: a synaptic perspective.
Dustin M
Fac Rev. 2023; 12:25.
PMID: 37900153
PMC: 10608137.
DOI: 10.12703/r/12-25.
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways.
Chan W, Cao Y, Zhao X, Schrom E, Jia D, Song J
J Exp Med. 2023; 220(12).
PMID: 37796477
PMC: 10555889.
DOI: 10.1084/jem.20231242.
Light-inducible T cell engagers trigger, tune, and shape the activation of primary T cells.
Jaeger M, Anastasio A, Chamy L, Brustlein S, Vincentelli R, Durbesson F
Proc Natl Acad Sci U S A. 2023; 120(39):e2302500120.
PMID: 37722050
PMC: 10523538.
DOI: 10.1073/pnas.2302500120.
Refining chimeric antigen receptors via barcoded protein domain combination pooled screening.
Rios X, Pardias O, Morales M, Bhattacharya P, Chen Y, Guo L
Mol Ther. 2023; 31(11):3210-3224.
PMID: 37705245
PMC: 10638030.
DOI: 10.1016/j.ymthe.2023.09.008.